Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Cytobioteck
Bogotá, Cundinamarca, Colombia
- Ownership
- Private
- Employees
- ~1
- Development stage
- Other
01
Overview
Cytobioteck is a Latin American pharmaceutical company that in-licenses and commercializes prescription medicines from international partners in multiple specialty areas; it focuses on market access and distribution rather than internal drug discovery or clinical development.
- Therapeutic areas
- HematologyNephrologyImmunologyEndocrinologyCardiovascularNeurologyPulmonologyRare DiseasesGastroenterologyOncology
- Modalities
- Small molecule
- Industry
- Non-Academic Healthcare
02
Partnerships
Pharming Group (exclusive distribution agreement for RUCONEST (conestat alfa) and possibly other products in Colombia and selected Latin American markets)
Beyond the preview
Go deeper on Cytobioteck.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Cytobioteck.